Neurocrine Clinical Site

Madrid 28922

1 studies enrolling now · 6 studies all time

What they study most

Cerebral Palsy, Congenital Adrenal Hyperplasia, Continuous Spike and Wave During Sleep, Dyskinesia, Epileptic Encephalopathy, Major Depressive Disorder, Schizophrenia

Studies at this site

• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) — Recruiting now
• Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia — Running, not enrolling
• Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy — Completed
• Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep — Stopped early
• Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep — Completed
• Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia — Stopped early